Shu Xu
- Pharmacology top 10%
-
- Cancer Genomics and Diagnostics 4
-
- Neuroinflammation and Neurodegeneration Mechanisms 2
- Transcranial Magnetic Stimulation Studies 2
-
- RNA Interference and Gene Delivery 5
- CRISPR and Genetic Engineering 5
- RNA regulation and disease 2
-
- Cancer Cells and Metastasis 2
- Pancreatic and Hepatic Oncology Research 2
- Co-authors
- Qian WangJianping LiuXun LiHuijuan CaoMei HanTing WuXiaozhong ZhouQin Jiang
- Journals
- Nucleic Acids Research (1 paper)SHILAP Revista de lepidopterología (1 paper)Biomaterials (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Shu Xu
25 papers receiving 468 citations
Peers
Comparison fields: 5 of 108
- Complementary and alternative medicine 82
- Pharmacology 54
- Cancer Research 79
- Pharmacology 46
- Neurology 22
Countries citing papers authored by Shu Xu
This map shows the geographic impact of Shu Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Xu more than expected).
Fields of papers citing papers by Shu Xu
This network shows the impact of papers produced by Shu Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Xu. The network helps show where Shu Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shu Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 10 | |
| 6 | 2023 | 12 | |
| 7 | 2022 | 9 | |
| 8 | 2021 | 3 | |
| 9 | 2021 | 41 | |
| 10 | 2021 | 25 | |
| 11 | 2020 | 67 | |
| 12 | 2019 | 6 | |
| 13 | 2018 | 0 | |
| 14 | 2017 | 5 | |
| 15 | 2016 | 26 | |
| 16 | 2015 | 19 | |
| 17 | 2012 | 8 | |
| 18 | 2010 | 111 | |
| 19 | 2008 | 12 | |
| 20 | 2008 | 50 |
About Shu Xu
Shu Xu is a scholar working on Neurology, Cancer Research and Oncology, having authored 30 papers that have together received 478 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (5 papers), CRISPR and Genetic Engineering (5 papers), Cancer Genomics and Diagnostics (4 papers), Neuroinflammation and Neurodegeneration Mechanisms (2 papers), Cancer Cells and Metastasis (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), RNA regulation and disease (2 papers) and Transcranial Magnetic Stimulation Studies (2 papers). The work is most often cited by research in Complementary and alternative medicine (82 citations), Pharmacology (54 citations) and Cancer Research (79 citations). Shu Xu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Qian Wang, Jianping Liu, Xun Li, Huijuan Cao, Mei Han, Ting Wu, Xiaozhong Zhou, Qin Jiang, Juping Chen and Ya Li. Their work appears in journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.